Corona Remedies Limited is an India-based pharmaceutical formulation company. The Company is engaged in developing, manufacturing and marketing products in women's healthcare, cardio-diabetes, pain management, urology and other/multispecialty pharmaceuticals (comprising vitamins/minerals/nutrition (VMN), gastrointestinal and respiratory). Its diverse product portfolio comprises approximately 67 brands catering to a range of therapeutic areas. It has four dosage forms in pain management formulations, which it offers in the form of tablets, capsules, sprays and injections for treatments associated with musculoskeletal spasms and diabetes. It holds brands across the women's healthcare lifecycle, from adolescence to infertility, pregnancy, post-pregnancy and pre- and post-menopause categories. Its brands include such as C-HOP; Trazer; COR; Cortel; Rosuless; Bisobis; Sitabite; Dapabite; Fur; Voglibite; Angiwell; Stimucor; Argihope, and others.
CORONA Remedies Ltd. FAQs
How to Buy CORONA Remedies Ltd. Share?
To purchase CORONA Remedies Ltd. shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for CORONA Remedies Ltd. (ticker symbol: CORONA) on the trading platform provided by your broker and purchase the shares.
What's CORONA Remedies Ltd. share price today?
The stock price of CORONA Remedies Ltd. as of 25 Feb 2026 is ₹1,579.97
What is the Market Cap of CORONA Remedies Ltd.?
Market capitalisation represents the total market value of a company's outstanding shares. As of 25 Feb 2026, CORONA Remedies Ltd. (ticker symbol: CORONA) has a market capitalisation of approximately ₹93,20,00,00,000.00
What is the PE and PB ratio of CORONA Remedies Ltd.?
CORONA Remedies Ltd. Ltd's price-to-book ratio as of 25 Feb 2026 is 15.94, reflecting the market's valuation compared to its asset value. As of 25 Feb 2026, the trailing twelve months P/E (price-to-earnings) ratio is 64.67, indicating the market values the company at around ₹64.67 for every ₹1 of earnings
What is the 52 Week High and Low of CORONA Remedies Ltd. Share?
CORONA Remedies Ltd. Ltd (CORONA) hit its 52-week high at ₹1,646.88, and its 52-week low at ₹1,314.38.